Coagulation system activation and increase of D‐dimer levels in peripheral arterial occlusive disease

The aim of the present study was to document coagulation system activation and basal fibrinolysis in peripheral arterial occlusive disease (PAOD) at stage II of Fontaine's classification. In 34 patients, prothrombin fragment (F1 + 2), thrombin‐antithrombin III complexes (TAT), and D‐dimer concentrations were evaluated before and after a standard treadmill test. Basal levels in PAOD of F1 + 2 (1.25 ± 0.19 nmol/liter) and of TAT (3.34 ± 0.35 μg/liter) were significantly increased compared to those obtained in age‐ and sex‐matched healthy controls (0.68 ± 0.06 nmol/liter and 2.30 ± 0.33 μg/liter, respectively), showing baseline activation of the clotting cascade. A secondary activation of the fibrinolytic system was evidenced by the highly significant increase of basal D‐dimers (719 ± 99 ng/dl in PAOD vs. 229 ± 37 ng/dl in controls). Treadmill exercise failed to increase the study parameters significantly further. Walking distance (583 ± 40 m) was correlated with the preexercise ankle to brachial systolic blood pressure ratio (r = 0.485, P < 0.005) and inversely with the level of D‐dimers (r = −0.425, P < 0.02). Under baseline conditions, the latter parameter was correlated as well with the antigen concentration of urokinase‐type plasminogen activator (u‐PA; r = 0.503, P < 0.002). These results indicate that stage II PAOD is characterized by an activation of the clotting cascade in baseline conditions evidenced by increased F1 + 2 and TAT. A secondary activation of the fibrinolytic system with increased u‐PA antigen levels accounts for the elevated D‐dimers. Treadmill exercise was unable to increase these parameters further.

[1]  E. Nabel,et al.  Biology of the impaired endothelium. , 1991, The American journal of cardiology.

[2]  H. Wada,et al.  Dynamic fluctuations in blood of thrombin/antithrombin III complex (TAT) , 1991, American journal of hematology.

[3]  J. Philippé,et al.  Fibrinolysis and Coagulation in Patients with Infectious Disease and Sepsis , 1991, Thrombosis and Haemostasis.

[4]  W. Stüber,et al.  Determination of Human Prothrombin Activation Fragment 1+2 in Plasma with an Antibody against a Synthetic Peptide , 1991, Thrombosis and Haemostasis.

[5]  D. Slosman,et al.  Measurement of D-dimer in plasma as diagnostic aid in suspected pulmonary embolism , 1991, The Lancet.

[6]  F. Neumann,et al.  Activation and decreased deformability of neutrophils after intermittent claudication. , 1990, Circulation.

[7]  P. Declerck,et al.  A monoclonal antibody specific for two-chain urokinase-type plasminogen activator. Application to the study of the mechanism of clot lysis with single-chain urokinase-type plasminogen activator in plasma. , 1990, Blood.

[8]  G. Lowe,et al.  Peripheral vascular disease. Rheologic variables during controlled ischemia. , 1989, Circulation.

[9]  J. Wojta,et al.  Vascular origin determines plasminogen activator expression in human endothelial cells. Renal endothelial cells produce large amounts of single chain urokinase type plasminogen activator. , 1989, The Journal of biological chemistry.

[10]  J. T. ten Cate,et al.  Laboratory and clinical evaluation of an assay of thrombin-antithrombin III complexes in plasma. , 1988, Clinical chemistry.

[11]  J. Loscalzo,et al.  Utility of cross-linked fibrin degradation products in the diagnosis of pulmonary embolism. , 1988, American heart journal.

[12]  R. Bertina,et al.  Hemostatic enzyme generation in the blood of patients with hereditary protein C deficiency. , 1988, Blood.

[13]  H. Pelzer,et al.  Determination of Human Thrombin-Antithrombin III Complex in Plasma with an Enzyme-Linked Immunosorbent Assay , 1988, Thrombosis and Haemostasis.

[14]  K. Bauer,et al.  Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses. , 1987, The Journal of clinical investigation.

[15]  E. Ernst,et al.  Intermittent claudication, exercise, and blood rheology. , 1987, Circulation.

[16]  Heaton Dc,et al.  Assessment of D dimer assays for the diagnosis of deep vein thrombosis. , 1987 .

[17]  K. Bauer,et al.  The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation. , 1987, Blood.

[18]  D. Collen,et al.  Assay of Human Tissue-Type Plasminogen Activator (t-PA) with an Enzyme-Linked Immunosorbent Assay (ELISA) Based on Three Murine Monoclonal Antibodies to t-PA , 1985, Thrombosis and Haemostasis.

[19]  K. Bauer,et al.  Thrombin generation in acute promyelocytic leukemia. , 1984, Blood.

[20]  G. Schattman,et al.  Red Cell Flexibility and Platelet Aggregation in Patients with Chronic Obstructive Vascular Disease (COAD) and Study of Therapeutic Approaches , 1984, Angiology.

[21]  D. Rylatt,et al.  Measurement of Crosslinked Fibrin Degradation Products – An Immunoassay Using Monoclonal Antibodies , 1983, Thrombosis and Haemostasis.

[22]  K. Bauer,et al.  Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1 + 2 fragment and thrombin--antithrombin complex. , 1982, Blood.

[23]  M. Hoylaerts,et al.  Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. , 1982, The Journal of biological chemistry.

[24]  F. Barbier,et al.  Platelet Activation During Treadmill Exercise In Patients With Chronic Peripheral Arterial Disease , 1981, Thrombosis and Haemostasis.

[25]  D. Beeler,et al.  The isolation and characterization of a specific antibody population directed against the prothrombin activation fragments F2 and F1 + 2. , 1979, The Journal of biological chemistry.

[26]  P. de Moerloose,et al.  Measurement of plasma D-dimer for diagnosis of deep venous thrombosis. , 1989, American Journal of Clinical Pathology.

[27]  T. Terao,et al.  Preeclampsia as chronic disseminated intravascular coagulation. Study of two parameters: thrombin-antithrombin III complex and D-dimers. , 1987, Gynecologic and obstetric investigation.